What is the prevalence of Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)?

TL;DR: While the exact prevalence of Anterior Cutaneous Nerve Entrapment Syndrome (ACNES) remains unknown due to widespread underdiagnosis, it is estimated to be a common cause of chronic abdominal wall pain, accounting for approximately 2% to 30% of cases in primary care settings. Because it is frequently misdiagnosed as visceral pathology, true epidemiological data is difficult to capture, though it is recognized as a distinct clinical entity rather than an ultra-rare condition.

Is Anterior Cutaneous Nerve Entrapment Syndrome (ACNES) common?

Anterior Cutaneous Nerve Entrapment Syndrome (ACNES) is frequently under-recognized by clinicians, leading to a significant gap between actual incidence and documented cases. Research suggests that among patients presenting with chronic abdominal pain, Anterior Cutaneous Nerve Entrapment Syndrome (ACNES) is a frequent, yet overlooked, diagnosis. It is not considered an "ultra-rare" disease in terms of biological frequency, but it remains "medically rare" in terms of diagnostic awareness.

Who is most affected by Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)?

The condition affects both genders, though clinical literature consistently reports a higher prevalence in females, often by a ratio of 2:1 or 3:1. While Anterior Cutaneous Nerve Entrapment Syndrome (ACNES) can occur at any age, it is most commonly diagnosed in adults, particularly those in their 30s to 50s. Pediatric cases are documented but less frequently reported in literature.

Why is accurate data on Anterior Cutaneous Nerve Entrapment Syndrome (ACNES) difficult to obtain?

The primary challenge in mapping the prevalence of Anterior Cutaneous Nerve Entrapment Syndrome (ACNES) is the "diagnostic odyssey" patients face. Because the pain is localized to the abdominal wall but mimics visceral organ disease (like IBS or gynecological issues), patients often undergo unnecessary imaging and invasive procedures. Our DiseaseMaps.org community, which includes 36 individuals living with this condition, reflects this reality; many members report years of seeking answers before receiving an accurate diagnosis.

Key clinical observations regarding patient demographics:

• Gender bias: Females are affected significantly more often than males, possibly due to hormonal influences or anatomical differences in the abdominal wall.


• Misdiagnosis rates: Studies indicate that many patients are initially mislabeled with functional gastrointestinal disorders.


• Diagnostic indicators: The presence of a positive Carnett’s sign is a crucial clinical tool to distinguish Anterior Cutaneous Nerve Entrapment Syndrome (ACNES) from intra-abdominal pathology.

Next steps

• Consult a surgeon or a pain management specialist familiar with abdominal wall nerve entrapment.


• Perform a self-assessment using the Carnett’s sign test under the guidance of a physician.


• Connect with the 36 members of our DiseaseMaps.org community to share experiences and diagnostic pathways.


• Keep a detailed pain diary to track triggers and localized tenderness.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Database of rare diseases and orphan drugs


• PubMed: Systematic reviews on the diagnostic accuracy of Carnett’s sign in ACNES


• The ACNES Foundation: Clinical and patient-reported outcomes data